当前位置: 首页 > 医疗版 > 疾病专题 > 呼吸内科 > 弥漫性间质性肺病 > 特发性肺纤维化
编号:13472736
芪归方有效组分治疗特发性肺纤维化的实验研究(1)
http://www.100md.com 2020年6月15日 《世界中医药》 202012
     摘要 目的:基于Smurf2串話TGF-β1/Smad信号通路研究芪归方有效组分对转化生长因子β1(TGF-β1)诱导人胚肺成纤维细胞MRC-5的影响及机制。方法:体外予以10 ng/mL TGF-β1培养MRC-5细胞,PCR仪检测α-SMA的mRNA水平判断模型是否成功。设立正常对照组、模型组(10 ng/mL TGF-β1处理)、泼尼松处理组、芪归方有效组分高剂量组、中剂量组、低剂量组,采用CCK-8法检测MRC-5的增殖情况,Western blot检测各组细胞Smad7、SnoN蛋白的表达水平,RT-PCR检测各组细胞Smurf2的mRNA水平。结果:与正常对照组比较,48 h模型组细胞增殖明显,α-SMA的mRNA水平增加(P<0.01),造模成功。经10 ng/mL TGF-β1处理细胞MRC-5,与正常对照组比较,Smad7、SnoN蛋白水平显著降低,Smurf2蛋白mRNA水平升高(P<0.01或P<0.05)。不同浓度芪归方有效成分处理组细胞增殖降低,可逆转以上各指标的改变,呈一定的量效关系。结论:芪归方有效组分能抑制MRC-5细胞增殖,可通过减少MRC-5细胞中Smurf2所介导的Smad7、SnoN的泛素化,恢复Smad7、SnoN蛋白的表达,从而调节肺纤维化的发生发展。

    关键词 芪归方有效组分;Smad泛素化调节因子2;Smad蛋白;核转录共抑制因子;特发性肺纤维化

    Abstract Objective:Based on Smurf2 crosstalk TGF-β1/Smad signaling pathway to study the effect and mechanism of Qigui Fomula active components on transforming growth factor β1 (TGF-β1)-induced human embryo lung fibroblast MRC-5. Methods:MRC-5 was cultured with 10 ng/mL TGF-β1 in vitro, mRNA level of α-SMA was detected by PCR instrument to judge whether the model was successfully made. Normal control group, model group (10 ng/mL TGF-β1 treatment), prednisone treatment group, high-dose group, middle-dose group and low-dose group of effective components of Qigui Fomula were set, CCK-8 method was used to detect the proliferation of MRC-5, Western blot was used to detect the expression level of Smad7 and SnoN protein in each group, and RT-PCR was used to detect the mRNA level of Smurf2 in each group. Results:Compared with the normal control group, the 48 h model group had significant cell proliferation, and the mRNA level of α-SMA increased (P<0.01), and the modeling was successful. Compared with the normal control group, MRC-5 treated with 10 ng/mL TGF-β1 showed that Smad7 and SnoN protein levels were significantly reduced and Smurf2 protein mRNA levels were increased (P<0.01 or P<0.05). The cell proliferation of the Qigui Foluma group with different concentrations was reduced, which could reverse the changes of the above indicators and showed a certain dose-effect relationship. Conclusion:The effective components of Qigui Foluma can inhibit the proliferation of MRC-5 cells, and can reduce the ubiquitination of Smad7 and SnoN mediated by Smurf2 in MRC-5 cells, restore the expression of Smad7 and SnoN proteins, and thereby regulate the occurrence of pulmonary fibrosis development.

    Keywords Effective Component of Qigui Foluma; Smad ubiquitination regulator 2; Smad protein;Nuclear transcription co-suppressor; Idiopathic pulmonary fibrosis, 百拇医药(彭艳芳 张莹雯 张亚兵)
1 2 3 4 5下一页


    参见:首页 > 医疗版 > 疾病专题 > 呼吸内科 > 弥漫性间质性肺病 > 特发性肺纤维化